CM Life Sciences II Inc.
| General Information | |
| Business: | Our team intends to leverage the strong life sciences knowledge base and public and private market experience of our sponsor with the goal of executing a successful business combination in the life sciences sector. Our sponsor is an affiliate of Eli Casdin, founder and Chief Investment Officer of Casdin Capital, and of Keith Meister, founder and Chief Investment Officer of Corvex Management, two leading investment firms. (Note: CM Life Sciences II priced its upsized SPAC IPO on Feb. 22, 2021: 24 million units, up from 20 million units, at $10 each to raise $240 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2020 |
| Contact Information | |
| Address | c/o Corvex Management LP 667 Madison Avenue New York, New York 10065 |
| Phone Number | (212) 474-6745 |
| Web Address | |
| View Prospectus: | CM Life Sciences II Inc. |
| Financial Information | |
| Market Cap | $290.0mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | CMIIU |
| Exchange | NYSE |
| Shares (millions): | 24.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $240.0 mil |
| Manager / Joint Managers | Jefferies |
| CO-Managers | - |
| Expected To Trade: | 2/23/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |